RAC Strategic Planning & Communication 2 — Questions and Answers
Question 1: A regulatory affairs team is preparing a risk-based submission strategy for a novel medical device. Which factor MOST influences the choice between a 510(k) and a PMA pathway?
- Device manufacturing location
- The level of risk the device poses to patients (Correct answer)
- The number of intended users
- Market size of the intended indication
Correct answer: The level of risk the device poses to patients
The FDA classification system and associated submission pathway (510(k) vs. PMA) are primarily determined by the risk level of the device to patients.
Question 2: Which communication approach is MOST effective when a regulatory agency issues a deficiency letter requesting additional clinical data?
- Immediately escalate to company legal counsel and delay response
- Acknowledge receipt, request a meeting to clarify scope, and provide a detailed response plan with timelines (Correct answer)
- Submit the missing data without addressing each deficiency item individually
- Withdraw the submission and file a new one with the additional data
Correct answer: Acknowledge receipt, request a meeting to clarify scope, and provide a detailed response plan with timelines
Acknowledging receipt, seeking clarification, and providing a structured response plan demonstrates professionalism and helps avoid misunderstandings with the agency.
Question 3: When developing a global regulatory strategy for a pharmaceutical product, which of the following BEST describes a rolling submission approach?
- Submitting separate applications simultaneously to all target markets
- Submitting completed dossier sections to the agency as they become available rather than waiting for the full dossier (Correct answer)
- Rolling over a previously approved submission to a new indication
- Updating an existing submission on a scheduled annual basis
Correct answer: Submitting completed dossier sections to the agency as they become available rather than waiting for the full dossier
A rolling submission allows sponsors to submit completed sections of a marketing application progressively, often used to expedite review for promising therapies.
Question 4: A company's regulatory team must brief senior leadership on a complex FDA response. What is the MOST important principle when communicating technical regulatory information to non-expert executives?
- Include all raw data tables to ensure completeness
- Use precise regulatory jargon to maintain credibility
- Translate technical findings into business impact language with clear action items (Correct answer)
- Defer the briefing until all uncertainties are resolved
Correct answer: Translate technical findings into business impact language with clear action items
Effective communication to executives requires framing regulatory information in terms of business risk, timelines, and required decisions rather than technical detail.
Question 5: Which regulatory strategy tool is MOST useful for systematically mapping global market entry requirements across multiple regions?
- SWOT analysis
- Regulatory intelligence matrix (Correct answer)
- GANTT chart
- Product risk profile
Correct answer: Regulatory intelligence matrix
A regulatory intelligence matrix organizes country-specific requirements, timelines, and submission formats, enabling strategic comparison across target markets.
Question 6: Under FDA's IND regulations, a sponsor must notify the agency and place a clinical hold if which situation arises?
- A principal investigator changes institutions
- An unexpected serious adverse event suggests an unreasonable risk to subjects (Correct answer)
- A contract research organization is replaced mid-study
- The study budget is revised significantly
Correct answer: An unexpected serious adverse event suggests an unreasonable risk to subjects
An unexpected serious adverse event (SUSAR) that suggests unreasonable risk to subjects triggers a clinical hold obligation under 21 CFR 312.
Question 7: When aligning cross-functional teams on a regulatory submission timeline, which planning technique BEST identifies tasks that could delay the overall project if not completed on time?
- Resource leveling
- Critical path analysis (Correct answer)
- Stakeholder mapping
- Risk matrix scoring
Correct answer: Critical path analysis
Critical path analysis identifies the sequence of dependent tasks that determines the minimum project duration and highlights tasks where any delay impacts the final deadline.
RAC Strategic Planning & Communication 2
A regulatory affairs team is preparing a risk-based submission strategy for a novel medical device.
Which factor MOST influences the choice between a 510(k) and a PMA pathway?